BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16537661)

  • 1. Pharmacotherapy for prehypertension--mission accomplished?
    Schunkert H
    N Engl J Med; 2006 Apr; 354(16):1742-4. PubMed ID: 16537661
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating prehypertension.
    Conen D; Martina B
    N Engl J Med; 2006 Jul; 355(4):417; author reply 417-8. PubMed ID: 16871687
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating prehypertension.
    Grassi DG
    N Engl J Med; 2006 Jul; 355(4):416; author reply 417-8. PubMed ID: 16870923
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating prehypertension.
    Lopez-Plasencia Y; Amela-Peris R; Garcia-Delgado Y
    N Engl J Med; 2006 Jul; 355(4):416-7; author reply 417-8. PubMed ID: 16874902
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating prehypertension.
    Baumann M; van den Born BJ
    N Engl J Med; 2006 Jul; 355(4):416-8; author reply. PubMed ID: 16874901
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)].
    Mann J
    Internist (Berl); 2007 Apr; 48(4):436-8. PubMed ID: 17342351
    [No Abstract]   [Full Text] [Related]  

  • 7. [CASE-J].
    Fukui T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():449-53. PubMed ID: 16981578
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspectives on prehypertension.
    Nesbitt SD
    J Cardiometab Syndr; 2006; 1(5):364-5. PubMed ID: 17679784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II Receptor Antagonists: Can they Go Beyond ACE Inhibitors? Proceedings of a satellite symposium to the 15th scientific meeting of the International Society of Hypertension. Melbourne, Australia, March 1994.
    Blood Press Suppl; 1994; 5():1-133. PubMed ID: 7889189
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
    Franke H
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S61-2. PubMed ID: 9331010
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
    Andersson OK; Neldam S
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
    Bönner G; Fuchs W
    Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension after kidney transplantation: still a SECRET?
    Lopau K; Wanner C
    Nephrol Dial Transplant; 2010 Mar; 25(3):664-5. PubMed ID: 20042402
    [No Abstract]   [Full Text] [Related]  

  • 14. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
    Zanchetti A; Omboni S; Di Biagio C
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
    [No Abstract]   [Full Text] [Related]  

  • 15. Experts ponder treating prehypertension.
    Mitka M
    JAMA; 2006 May; 295(18):2125-6. PubMed ID: 16684973
    [No Abstract]   [Full Text] [Related]  

  • 16. Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension.
    Heuer HJ; Schöndorfer G; Högemann AM
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S55-6. PubMed ID: 9331008
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving prognosis in hypertension: exploring the benefits of angiotensin II type 1 receptor blockade.
    Ruilope L
    Blood Press Suppl; 2000; 1():31-5. PubMed ID: 11059634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil.
    Unger T
    Blood Press Suppl; 2000; 1():14-8. PubMed ID: 11059630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PPARgamma-activating properties of angiotensin receptor blockers].
    Ando H; Fujimura A
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():498-501. PubMed ID: 16895217
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment options for prehypertension.
    Nesbitt SD
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):250-5. PubMed ID: 17420669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.